一次性生物製程市場規模、佔有率及成長分析（按產品、應用和地區分類）－2026-2033年產業預測

預計到 2024 年，一次性生物加工市場價值將達到 177 億美元，到 2025 年將成長至 202.7 億美元，到 2033 年將成長至 598.8 億美元，在預測期（2026-2033 年）內複合年成長率為 14.5%。

一次性生物製程市場正經歷顯著成長，這主要得益於一次性技術的日益普及，這些技術能夠降低設施建設成本和縮短工期。製造業對一次性產品的日益青睞以及先進設備創新的湧現，進一步推動了這一成長動能。新參與企業和老牌供應商都在推出功能強大的一次性解決方案，以增強其在生物製藥領域的產品供應。此外，創新自動化技術的整合以及巨量資料分析的進步預計將對市場動態積極影響，並推動一次性生物製程解決方案的需求。總而言之，這些因素都強烈表明該領域具有持續擴張的潛力，並凸顯了其在生物程序領域的關鍵地位。

一次性生物加工市場促進因素

全球人口老化預計將顯著推動一次性生物製程市場的發展。隨著65歲及以上人口數量的持續成長，為滿足其醫療需求，對生物製藥的需求勢必增加。這種人口結構變化正促使製藥公司採用一次性生物製程系統，以提高營運效率並降低成本。業界主要企業關注如何利用這些創新系統來滿足不斷成長的生物製藥產品需求，並有效應對老齡化人口的醫療需求。

限制一次性生物加工市場發展的因素

全球一次性生物加工市場的主要限制因素之一是其廢棄物處理可能帶來的環境影響。儘管這些系統在生物製造方面具有高效性和柔軟性，但人們對塑膠廢棄物和永續性的擔憂可能會阻礙其廣泛應用。包括監管機構和具有環保意識的消費者在內的許多相關人員，越來越重視環保方法和材料。這種對永續性的日益關注迫使製造商在營運效率和負責任的廢棄物管理之間尋求平衡，這可能會給市場成長帶來挑戰，因為企業既要滿足效率需求，又要兼顧環境問題。

一次性生物製程市場趨勢

一次性生物製程市場正經歷強勁成長，這主要得益於技術的快速進步和研發領域的巨額投資。這一趨勢推動了先進一次性系統的應用和創新，有助於提高生物製造流程的營運效率並降低污染風險。各公司正積極在其產品組合中添加先進的一次性解決方案，以滿足對精簡高效且經濟實惠的生物製程方法日益成長的需求。隨著生物製藥公司尋求最佳化產能並應對複雜的監管要求，市場有望充分利用這些發展機遇，為生物製程技術領域的相關人員帶來盈利的利潤。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術進步
• 監管環境
• 案例研究
• 客戶和購買標準分析
• 貿易分析
• 原料分析

全球一次性生物製程市場規模（按產品和複合年成長率分類）（2026-2033 年）

• 裝置
  • 免洗生物反應器
  • 一次性過濾系統
  • 一次性混合系統
  • 一次性層析法系統
  • 其他一次性設備
• 消耗品
  • 免洗袋子和容器
  • 免洗濾芯
  • 免洗組件
  • 一次性層析管柱
  • 一次性感測器
  • 其他一次性耗材

全球一次性生物製程市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 過濾
• 細胞培養
• 混合物
• 純化
• 倉儲和運輸
• 其他

全球一次性生物製程市場規模（按工作流程和複合年成長率分類）（2026-2033 年）

• 上游生物製程
• 下游生物製程

全球一次性生物製程市場規模（依分子類型分類）及複合年成長率（2026-2033 年）

• 單株抗體
• 疫苗
• 治療性蛋白質和胜肽
• 細胞和基因治療

全球一次性生物製程市場規模（按最終用戶分類）及複合年成長率（2026-2033 年）

• 製藥和生物技術公司
• CROS 和 CMOS
• 其他最終用戶

全球一次性生物製程市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2021-2023年營收年比比較

主要企業簡介

• Sartorius AG
• Thermo Fisher Scientific
• Danaher Corporation（Cytiva）
• Eppendorf AG
• Merck KGaA
• 3M
• PBS Biotech Inc.
• CESCO Bioengineering Co. Ltd
• ABEC Inc.
• Celltainer Biotech BV
• Distek, Inc.
• OmniBRx Biotechnologies
• Boehringer Ingelheim
• Kuhner Shaker AG
• Avantor, Inc.
• Corning Incorporated
• Flexbiosys Inc.
• Parker Hannifin Corporation
• Meissner Filtration Products
• Repligen Corporation

結論與建議

Single Use Bioprocessing Market size was valued at USD 17.7 Billion in 2024 and is poised to grow from USD 20.27 Billion in 2025 to USD 59.88 Billion by 2033, growing at a CAGR of 14.5% during the forecast period (2026-2033).

The single-use bioprocessing market is experiencing significant growth driven by the increasing popularity of single-use technology, which reduces capital costs and construction time for facilities. The rising adoption of disposable products among manufacturing organizations and a surge in the innovation of advanced devices further fuel this momentum. New market entrants and existing vendors are introducing robust disposable solutions, enhancing product offerings in the biopharmaceutical sector. Additionally, the integration of innovative automation and advancements in big data analytics are poised to positively influence market dynamics, reinforcing the demand for single-use bioprocessing solutions. These factors collectively highlight the strong potential for continued expansion within this sector, underscoring its critical role in the bioprocessing landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Single Use Bioprocessing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Single Use Bioprocessing Market Segments Analysis

Global Single Use Bioprocessing Market is segmented by product, application, workflow, molecule type, end user and region. Based on product, the market is segmented into equipment and consumables. Based on application, the market is segmented into filtration, cell culture, mixing, purification, storage & transfer and other. Based on workflow, the market is segmented into upstream bioprocessing and downstream bioprocessing. Based on molecule type, the market is segmented into monoclonal antibodies, vaccines, therapeutic proteins & peptides and cell & gene therapies. Based on end user, the market is segmented into pharmaceutical & biotechnology companies, CROS & CMOS and other end users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Single Use Bioprocessing Market

The increasing global aging population is anticipated to significantly boost the single-use bioprocessing market. As the number of individuals aged 65 and older continues to grow, the demand for biopharmaceuticals will inevitably increase in response to their healthcare needs. This demographic shift is driving pharmaceutical companies to adopt single-use bioprocessing systems, as these technologies enhance operational efficiency and reduce costs. The industry is witnessing a heightened focus from major corporations on leveraging these innovative systems to meet the rising demand for biopharmaceutical products, ensuring that they cater effectively to the healthcare requirements of an aging populace.

Restraints in the Single Use Bioprocessing Market

One key market restraint for the global single-use bioprocessing market is the potential environmental impact associated with the disposal of single-use bioprocessing materials. While these systems offer efficiency and flexibility in biomanufacturing, concerns regarding plastic waste and sustainability can hinder their widespread adoption. Many stakeholders, including regulatory bodies and environmentally-conscious consumers, are increasingly prioritizing eco-friendly practices and materials. This growing emphasis on sustainability may compel manufacturers to balance operational efficiency with responsible waste management, posing challenges for the market growth as companies strive to meet both efficiency needs and environmental considerations.

Market Trends of the Single Use Bioprocessing Market

The single-use bioprocessing market is experiencing robust growth driven by a surge in technological advancements and significant investments in research and development. This trend is fostering increased innovation and the introduction of sophisticated single-use systems, enhancing operational efficiency and reducing contamination risks in biomanufacturing processes. Companies are actively expanding their portfolios to include advanced single-use disposable solutions, responding to the rising demand for streamlined and cost-effective bioprocessing methods. As biopharmaceutical companies seek to optimize production capabilities and navigate regulatory complexities, the market is poised to capitalize on these developments, offering lucrative opportunities for stakeholders in the evolving landscape of bioprocessing technologies.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies
• Customer & Buying Criteria Analysis
• Trade Analysis
• Raw Material Analysis

Global Single Use Bioprocessing Market Size by Product & CAGR (2026-2033)

• Market Overview
• Equipment
  • Single-Use Bioreactors
  • Single-Use Filtration Systems
  • Single-Use Mixing Systems
  • Single-Use Chromatography Systems
  • Other Single-Use Equipment
• Consumables
  • Single-Use Bags & Containers
  • Single-Use Filters
  • Single-Use Assemblies
  • Single-Use Chromatography Columns
  • Single-Use Sensors
  • Other Single-Use Consumables

Global Single Use Bioprocessing Market Size by Application & CAGR (2026-2033)

• Market Overview
• Filtration
• Cell Culture
• Mixing
• Purification
• Storage & Transfer
• Other

Global Single Use Bioprocessing Market Size by Workflow & CAGR (2026-2033)

• Market Overview
• Upstream Bioprocessing
• Downstream Bioprocessing

Global Single Use Bioprocessing Market Size by Molecule Type & CAGR (2026-2033)

• Market Overview
• Monoclonal Antibodies
• Vaccines
• Therapeutic Proteins & Peptides
• Cell & Gene Therapies

Global Single Use Bioprocessing Market Size by End User & CAGR (2026-2033)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• CROS & CMOS
• Other End Users

Global Single Use Bioprocessing Market Size & CAGR (2026-2033)

• North America (Product, Application, Workflow, Molecule Type, End User)
  • USA
  • Canada
• Europe (Product, Application, Workflow, Molecule Type, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, Workflow, Molecule Type, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, Workflow, Molecule Type, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, Workflow, Molecule Type, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Sartorius AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (Cytiva)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eppendorf AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 3M
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PBS Biotech Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CESCO Bioengineering Co. Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ABEC Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celltainer Biotech BV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Distek, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OmniBRx Biotechnologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boehringer Ingelheim
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kuhner Shaker AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Avantor, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corning Incorporated
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Flexbiosys Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Parker Hannifin Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meissner Filtration Products
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Repligen Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations